Speaking Engagement Preparing for Biosimilar Carve Outs: Will Skinny Labelling Work for Biosimilars? June 27, 2023 4:15 PM - 5:15 PM Boston, MA
Webinar Drafting Considerations to Provide Flexibility in Post Grant Proceedings - EP vs. US June 22, 2023 12:30 PM - 2:00 PM Virtual
Bylined Articles What Practitioners Need to Know About Patent Invalidity at the Federal Circuit IAM June 2, 2023 Michael Joffre, Ph.D. Anna G. Phillips David M. Silversmith
Press Release Chambers USA Exclusively Awards Sterne Kessler the Band 1 Patent Prosecution Ranking Among D.C. Firms Sterne, Kessler, Goldstein & Fox June 1, 2023
Client Alert IP Hot Topic: Imperative Information on the New Unified Patent Court (UPC) Launching June 1 Robert Greene Sterne May 30, 2023
Bylined Articles Why the Amgen Case Might Be About More Than Enablement Thomson Reuters Westlaw Today May 26, 2023 William H. Milliken
Client Alert In Dupree, Supreme Court Unanimously Decides “Purely Legal” Issues Decided at Summary Judgment are Preserved for Appeal William H. Milliken Michael Joffre, Ph.D. May 25, 2023
Bylined Articles A Deep Dive Into EU Unified Patent Court Policy Law360 May 24, 2023 Robert Greene Sterne
Successfully Claiming Antibody Patents in Europe and the U.S.: Incorporating Takeaways From the Latest Case Law Into Your Prosecution Strategy May 24, 2023 1:30 PM - 2:15 PM Amsterdam, the Netherlands
In the News Reactions to Amgen: Hard Work Ahead for Biotech Innovators and Attorneys Trying to Enable Genus Claims IPWatchdog May 22, 2023
In the News Sanofi Can Thank Thomas Edison And Samuel Morse For IP Win The National Law Journal May 19, 2023
In the News In Amgen-Sanofi Decision, High Court Sticks to Patent Law Script Bloomberg Law May 19, 2023
Client Alert US Supreme Court Refocuses the Test for Transformative Use Ivy Clarice Estoesta William H. Milliken May 19, 2023